Cooperation Agreement SOLACI-CRF/TCT

On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and CRF/TCT. The agreement was signed by SOLACI President, Dr. Oscar Mendiz, SOLACI Vicepresident, Dr. Jamil Abdala Saad, and CRF/TCT Excecutive Director, Mr. Johnnie White.

The agreement defines several areas of cooperation. Among others, an annual meeting “SOLACI in partnership with TCT”, featuring TCT@SOLACI sessions, organized and coordinated by CRF, with 3 faculty professors provided by TCT. During TCT meetings, SOLACI@TCT lectures, organized and coordinated by SOLACI, will be assigned a premium time schedule.

However, it is worth mentioning this agreement is just the beginning of a series of mutual cooperation activities, such as reciprocal web-site promotion and reciprocal meetings promotion (promotion of TCT during SOLACI Congress/Sessions and promotion of SOLACI during TCT events around the world, which includes meeting journals and flyers).

We would also like to highlight that as from August we will implement a mechanism for SOLACI members living in Latin-American to get a discount in TCTmd Gold memberships, soon to be officially announced.

This agreement has been welcomed by our sponsors and we are confident our associates will feel the same way, seeing the potential for growth and better promotion of cardiovascular intervention in Latin America.

With warm greetings,

Oscar Mendiz
SOLACI President

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....